Literature DB >> 15581548

Genomic instability in histologically normal breast tissues: implications for carcinogenesis.

Darrell L Ellsworth1, Rachel E Ellsworth, Michael N Liebman, Jeffrey A Hooke, Craig D Shriver.   

Abstract

Breast cancer is an important contributor to morbidity and mortality in society, but factors that affect the cause of the disease are poorly defined. Genomic instability drives tumorigenic processes in invasive carcinomas and premalignant breast lesions, and might promote the accumulation of genetic alterations in apparently normal tissues before histological abnormalities are detectable. Evidence suggests that genomic changes in breast parenchyma affect the behaviour of epithelial cells, and ultimately might affect tumour growth and progression. Inherent instability in genes that maintain genomic integrity, as well as exogenous chemicals and environmental pollutants, have been implicated in breast-cancer development. Although molecular mechanisms of tumorigenesis are unclear at present, carcinogenic agents could contribute to fields of genomic instability localised to specific areas of the breast. Understanding the functional importance of genomic instability in early carcinogenesis has important implications for improvement of diagnostic and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581548     DOI: 10.1016/S1470-2045(04)01653-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  14 in total

Review 1.  Matrix metalloproteinase-induced genomic instability.

Authors:  Derek C Radisky; Mina J Bissell
Journal:  Curr Opin Genet Dev       Date:  2005-12-27       Impact factor: 5.578

2.  Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.

Authors:  Anwar Hossain; Joy Gumin; Feng Gao; Javier Figueroa; Naoki Shinojima; Tatsuya Takezaki; Waldemar Priebe; Diana Villarreal; Seok-Gu Kang; Celine Joyce; Erik Sulman; Qianghu Wang; Frank C Marini; Michael Andreeff; Howard Colman; Frederick F Lang
Journal:  Stem Cells       Date:  2015-05-27       Impact factor: 6.277

3.  Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats.

Authors:  Kristy Kutanzi; Olga Kovalchuk
Journal:  Cancer Biol Ther       Date:  2013-05-10       Impact factor: 4.742

Review 4.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

5.  Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomes.

Authors:  Christopher Kasbek; Ching-Hui Yang; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

6.  Mps1 as a link between centrosomes and genomic instability.

Authors:  Christopher Kasbek; Ching-Hui Yang; Harold A Fisk
Journal:  Environ Mol Mutagen       Date:  2009-10       Impact factor: 3.216

7.  Molecular characterization of human breast tumor vascular cells.

Authors:  Rajendra Bhati; Cam Patterson; Chad A Livasy; Cheng Fan; David Ketelsen; Zhiyuan Hu; Evangeline Reynolds; Catherine Tanner; Dominic T Moore; Franco Gabrielli; Charles M Perou; Nancy Klauber-DeMore
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

Review 8.  Role of oxidatively induced DNA lesions in human pathogenesis.

Authors:  Olga A Sedelnikova; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Alexandros G Georgakilas; William M Bonner
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

Review 9.  Stromal induction of breast cancer: inflammation and invasion.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

10.  Underarm antiperspirants/deodorants and breast cancer.

Authors:  Philippa D Darbre
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.